Rifaximin 550mg Tablet primarily acts by inhibiting bacterial RNA synthesis. It binds to the beta-subunit of bacterial RNA polymerase, which is responsible for RNA transcription. This binding interferes with the synthesis of essential RNA molecules required for bacterial growth and survival. Rifaximin specifically targets bacterial RNA polymerase, showing high affinity for this enzyme in various bacterial species, including both gram-positive and gram-negative bacteria. By blocking RNA synthesis, Rifaximin prevents the bacteria from producing the proteins and components necessary for their replication and metabolic processes, ultimately leading to bacterial growth inhibition and bactericidal effects.
- Used for preventing and treating infections in the gastrointestinal tract.
- Used to support the gut microbiome by selectively targeting harmful bacteria.
- Used in combination with other medications for comprehensive gastrointestinal treatment.
Composition
Each film coated contains:
- Rifaximin: 550 mg
Directions for Use
- As directed by a registered medical practitioner.
